FPF
ASMB icon

FNY Partners Fund’s Assembly Biosciences ASMB Stock Holding History

FNY Partners Fund’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-458
Closed -$113K – 555
2017
Q2 		$113K Hold
458
– – 0.03% 202
2017
Q1 		$140K Buy
+458
New +$112K 0.02% 419

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

FNY Partners Fund's ASMB Position: Q3 2017 in Review

FNY Partners Fund sold out of Assembly Biosciences (ASMB) in Q3 2017, closing a stake of 458 shares — an estimated $113K sold.

FNY Partners Fund first reported a position in ASMB in Q1 2017 and held it in 2 quarters. The position peaked at $140K in Q1 2017. 72 funds tracked by Wall St. Rank hold ASMB as of Q3 2017.

  • FNY Partners Fund reported no remaining Assembly Biosciences position as of Q3 2017 after selling out during the quarter.
  • FNY Partners Fund sold 458 Assembly Biosciences shares in Q3 2017, an estimated $113K.
  • FNY Partners Fund first reported a position in Assembly Biosciences in Q1 2017 and held it in 2 quarters.
  • FNY Partners Fund's Assembly Biosciences position peaked at $140K in Q1 2017.
  • 72 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2017.

Based on FNY Partners Fund's 13F filing for Q3 2017, filed 9 Nov 2017.